Blattes et al.
occurred leading to a 2/3 vs 1/3 mixture of diastereoisomers,
as already reported for similar derivatives.19 The NOE effect
was no more observed with the minor isomer: H NMR (500
MHz, CDCl3) δ 1.20 (s, 3H), 1.45-2.12 (m, 8H), 4.23 (s, 1H),
4.30 (s, 1H), 6.45 (d, J ) 9 Hz, 1H), 7.10 (d, J ) 9 Hz, 1H),
7.50 (m, 3H), 7.67 (d, J ) 7 Hz, 2H), 12.81 (s, 1H); 13C NMR
(100 MHz, CDCl3) δ 20.6, 22.0, 22.9, 30.8, 35.6, 53.9, 99.8,
109.4, 113.6, 120.7, 125.8, 128.7, 129.4, 132.0, 138.7, 148.1,
153.3, 201.2.
generate libraries of heterocycles which constitute the
molecular framework of medicinally relevant compounds.
Finally, as a result of their structural similarity with a
series of topologically different 1,4-benzoxazine deriva-
tives reported earlier,16 the biological evaluation of these
new benzoxazine derivatives as neuroprotective agents
is currently in progress and will be reported elsewhere.
1
[(R,S)-5-Hydr oxy-3-ph en yl-2-ph en yleth ylam in o-2H-1,4-
ben zoxa zin -6-yl](p h en yl)m eth a n on e 8. 3,4-Aminophenol
1r ed (114.5 mg, 0.5 mmol) and phenylethylamine (1.3 mL, 10
mmol) were added to a 0.02 M solution of TEAP (1.15 g, 5
mmol) in MeOH (250 mL). The resulting solution was then
oxidized under nitrogen, at room temperature, at a mercury
pool whose potential was fixed at +50 mV vs SCE (initial
current 45 mA). After exhaustive electrolysis (6 h, n ) 10),
the electrolysis solution was concentrated until the 1,4-
benzoxazine derivative precipitates in full. Then, the yellow
solid was collected by filtration, washed with small fractions
of MeOH, and dried in a vacuum desiccator (130 mg, 0.29
mmol, 58% yield): mp 193-195 °C; 1H NMR (300 MHz, CDCl3)
δ 2.35 (m, 1H), 2.85 (m, 2H), 3.20 (m, 1H), 3.28 (m, 1H), 5.95
(d, J ) 11 Hz, 1H), 6.58 (d, J ) 9 Hz, 1H), 7.15 (d, J ) 7 Hz,
2H), 7.25 (m, 3H), 7.40-7.60 (m, 7H), 7.70 (d, J ) 7 Hz, 2H),
8.00 (d, J ) 7 Hz, 2H), 13.10 (s, 1H); 13C NMR (75 MHz, CDCl3)
δ 37.2, 46.6, 81.8, 108.8, 114.7, 123.1, 126.8, 127.9, 128.8, 128.9,
129.0, 129.2, 129.5, 131.4, 132.2, 134.2, 135.6, 138.6, 139.7,
151.4, 155.4, 161.1, 200.9; MS DCI m/z 449 (MH+). Anal. Calcd
for C29H24N2O3: C, 77.68; H, 5.36; N, 6.25. Found: C, 77.59;
H, 5.46; N, 6.24.
[(R,S)-2-(2,2-Dim eth oxy)eth yla m in o-3,3-d ip h en yl-5-h y-
d r oxy-3,4-d ih yd r o-2H-1,4-ben zoxa zin -6-yl](p h en yl)m eth -
a n on e 23. Freshly distilled enamine (425 mg, 1.5 mmol) was
dissolved in methanol (250 mL) that contained TEAP (1.15 g,
5 mmol), along with 2,2-dimethoxyethylamine (55 µL, 0.5
mmol). The addition of the latter was necessary to produce
the monoanionic species of 1r ed , which was the sole form that
can be oxidized to o-azaquinone 1ox. Then, 3,4-aminophenol
1r ed (114.5 mg, 0.5 mmol) was added by small portions (22.9
mg, 0.1 mmol) to the solution which was oxidized at a mercury
pool whose potential was fixed at +50 mV vs SCE, under
nitrogen, at room temperature. After exhaustive electrolysis
(4 h, n)2), the solvent was removed under reduced pressure.
The brown oil residue was then poured into diethyl ether (20
mL). Insoluble TEAP was filtered off and the filtrate was
evaporated under reduced pressure, at 30 °C. Flash chroma-
tography of the residue on silica gel with toluene/acetone 98/2
v/v as the eluent afforded the expected 1,4-benzoxazine 23 in
55% yield (140 mg, 0.274 mmol) as a yellow solid which was
recrystallized from ether: mp 154-156 °C; 1H NMR (300 MHz,
CDCl3) δ 2.45 (m, 1H), 2.95 (m, 2H), 3.30 (s, 3H), 3.35 (s, 1H),
4.30 (t, J ) 6 Hz, 1H), 5.20 (s, 1H), 5.80 (d, J ) 11 Hz, 1H),
6.35 (d, J ) 9 Hz, 1H), 6.95 (d, J ) 9 Hz, 1H), 7.10-7.55 (m,
13H), 7.70 (d, J ) 8 Hz, 2H), 12.85 (s, 1H); 13C NMR (75 MHz,
CDCl3) δ 46.9, 53.4, 54.0, 62.3, 89.4, 104.1, 108.7, 112.7, 120.7,
124.5, 126.6, 126.8, 127.0, 128.0, 128.1, 128.3, 128.8, 131.2,
138.3, 143.0, 144.1, 147.0, 152.3, 201.5; MS DCI m/z 511
(MH+). Anal. Calcd for C31H30N2O5: C, 72.94; H, 5.88; N, 5.49.
Found: C, 72.87; H, 5.95; N, 5.47.
Exp er im en ta l Section
Chemicals were commercial products of the highest avail-
able purity and were used as supplied. Reduced catalyst 1r ed
was synthesized as previously reported.17 All apparatus, cells,
and electrodes were identical with those described previously.18
[(R,S)-2-Cycloh exylm eth yla m in o-5-h yd r oxy-3-sp ir o-1′-
cycloh exyl-3,4-d ih yd r o-2H-1,4-ben zoxa zin -6-yl](p h en yl)-
m eth a n on e 2a . 3,4-Aminophenol 1r ed (114.5 mg, 0.5 mmol)
and aminomethylcyclohexane (1.3 mL, 10 mmol) were added
to a 0.02 M solution of tetraethylammonium perchlorate
(TEAP) (1.15 g, 5 mmol) as the supporting electrolyte in MeOH
(250 mL). The resulting solution was then oxidized under
nitrogen, at room temperature, at a mercury pool whose
potential was fixed at +50 mV vs SCE (initial current 50 mA).
After exhaustive electrolysis (8 h, n ) 16), that is, when a
negligible current was recorded (1 mA), the solution was
neutralized with dry ice and the solvent was removed under
reduced pressure. The brown oil residue was then poured into
diethyl ether (20 mL). Insoluble TEAP was filtered off, and
the filtrate was evaporated under reduced pressure at 30 °C.
Flash chromatography of the residue on silica gel with toluene
as the eluent afforded the expected 1,4-benzoxazine 2a in 77%
yield (167 mg, 0.385 mmol) as a yellow solid which was
recrystallized from pentane/ether (60/40): mp 129-131 °C; 1H
NMR (300 MHz, CDCl3) δ 0.85-1.80 (m, 21H), 1.95 (s, 1H),
2.55 (m, 1H), 2.75 (m, 1H), 4.30 (s, 1H), 4.75 (s, 1H), 6.35 (d,
J ) 9 Hz, 1H), 7.00 (d, J ) 9 Hz, 1H), 7.50 (m, 3H), 7.70 (d, J
) 8 Hz, 2H), 12.75 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 21.2,
21.4, 25.5, 26.0, 26.6, 31.2, 33.2, 33.5, 38.5, 51.6, 51.9, 91.8,
108.7, 112.6, 120.6, 123.8, 128.0, 128.8, 131.1, 138.5, 147.2,
152.1, 203.0; MS DCI m/z 435 (MH+). Anal. Calcd for
C
27H34N2O3: C, 74.65; H, 7.83; N, 6.45. Found: C, 74.56; H,
8.11; N, 6.42.
[(5a R ,9a S )-1,5a -Dih yd r oxy-9a -m e t h yl-6,7,8,9,9a ,10-
h exa h yd r o-5a H-p h en oxa zin -2-yl](p h en yl)m eth a n on e 7b.
Isolated as a single diastereoisomer with cis configuration:
yellow solid recrystallized in ether; mp ) 192-194 °C; 1H NMR
(500 MHz, CDCl3) δ 1.40 (s, 3H), 1.45-1.90 (m, 7H), 2.12 (d,
J ) 14.5 Hz, 1H), 3.54 (s, 1H), 4.02 (s, 1H), 6.43 (d, J ) 9 Hz,
1H), 7.02 (d, J ) 9 Hz, 1H), 7.50 (m, 3H), 7.67 (d, J ) 7 Hz,
2H), 12.72 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 20.6, 22.0,
22.8, 33.2, 35.1, 53.9, 99.3, 108.8, 113.5, 120.1, 124.5, 128.7,
129.4, 131.9, 138.8, 147.2, 152.5, 201.2; MS DCI m/z 340
(MH+). Anal. Calcd for C20H21NO4: C, 70.79; H, 6.19; N, 4.13.
Found: C, 70.54; H, 6.41; N, 4.14. The cis junction of the
bicyclic system was established on the basis of NOE experi-
ments (mixing time: 250 ms): a NOE effect was observed
between the 9a-angular methyl substituent (1.40 ppm) and
the 5a-hydroxy group (3.54 ppm). The stereochemical assign-
ment was confirmed when the hemiacetal cycloadduct 7b was
exposed for 48h in CDCl3; then, a cis-trans equilibrium
Ack n ow led gm en t. We thank the Servier Co. for
financial support of this research.
(15) It is known that secondary alkylenamines are thermodynami-
cally unstable at room temperature and that the imino form is the
sole detectable species; see: B. De J eso, J .-C. Pommier J . Chem. Soc.,
Chem. Commun. 1977, 565 and references therein.
(16) (a) Largeron, M.; Lockhart, B.; Pfeiffer, B.; Fleury, M.-B. J . Med.
Chem. 1999, 42, 5043. (b) Largeron, M.; Mesples, P.; Gressens, P.;
Cechelli, R.; Spedding, M.; Le Ridant, A.; Fleury, M.-B. Eur. J .
Pharmacol. 2001, 424, 189.
(17) Larget, R.; Lockhart, B.; Pfeiffer, B.; Neudorffer, A.; Fleury, M.-
B.; Largeron, M. Bioorg. Med. Chem. Lett. 1999, 9, 2929.
(18) Largeron, M.; Neudorffer, A.; Fleury, M.-B. J . Chem. Soc.,
Perkin Trans. 2 1998, 2721.
Su p p or tin g In for m a tion Ava ila ble: General experimen-
1
tal methods, H/13C NMR and MS spectral data, CHN analy-
ses, and melting points for substituted benzoxazine derivatives
2b-7a , 9-22, and 24-35. This material is available free of
J O035614B
(19) (a) Levine, S. G.; Gragg, C.; Bordner, J . J . Org. Chem. 1976,
41, 4026. (b) Herzig, C.; Gasteiger, J . Chem. Ber. 1981, 114, 2348.
890 J . Org. Chem., Vol. 69, No. 3, 2004